ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 44 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $23,000 | +21.1% | 46,937 | -3.0% | 0.00% | – |
| Q4 2018 | $19,000 | -47.2% | 48,402 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | +16.1% | 48,402 | 0.0% | 0.00% | – |
| Q2 2018 | $31,000 | +34.8% | 48,402 | -22.9% | 0.00% | – |
| Q1 2018 | $23,000 | -34.3% | 62,790 | +17.9% | 0.00% | – |
| Q4 2017 | $35,000 | +25.0% | 53,277 | +10.1% | 0.00% | – |
| Q3 2017 | $28,000 | -52.5% | 48,402 | 0.0% | 0.00% | – |
| Q2 2017 | $59,000 | -19.2% | 48,402 | 0.0% | 0.00% | – |
| Q1 2017 | $73,000 | +69.8% | 48,402 | -1.4% | 0.00% | – |
| Q4 2016 | $43,000 | -38.6% | 49,084 | -4.8% | 0.00% | – |
| Q3 2016 | $70,000 | -59.1% | 51,583 | -46.7% | 0.00% | – |
| Q2 2016 | $171,000 | -10.9% | 96,807 | +0.2% | 0.00% | – |
| Q1 2016 | $192,000 | -38.5% | 96,571 | 0.0% | 0.00% | – |
| Q4 2015 | $312,000 | +578.3% | 96,571 | +273.5% | 0.00% | – |
| Q3 2015 | $46,000 | -33.3% | 25,857 | 0.0% | 0.00% | – |
| Q2 2015 | $69,000 | -84.1% | 25,857 | -85.3% | 0.00% | – |
| Q1 2015 | $433,000 | -7.3% | 175,401 | +121.3% | 0.00% | – |
| Q4 2014 | $467,000 | -13.7% | 79,276 | -1.8% | 0.00% | – |
| Q3 2014 | $541,000 | -47.9% | 80,719 | -43.8% | 0.00% | – |
| Q2 2014 | $1,038,000 | – | 143,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |